Biotechnology in Japan

Biotechnology in Japan

Summary

Biotechnology in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- The biotechnology industry consists of the development, manufacturing, and industrying of products based on advanced biotechnology research.
- The Japanese biotechnology industry had total revenues of $37.4bn in 2018, representing a compound annual growth rate (CAGR) of 3.1% between 2014 and 2018.
- The environment & industrial processing segment was the industry's most lucrative in 2018, with total revenues of $14.6bn, equivalent to 38.9% of the industry's overall value.
- The Japanese industry is very mature, and accounted for 37.6% of the total value of the Asia-Pacific region’s value in 2018, making it the region’s largest industry. The maturity of the industry therefore means that growth is stunted.

Scope

- Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the biotechnology market in Japan
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the biotechnology market in Japan
- Leading company profiles reveal details of key biotechnology market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Japan biotechnology market with five year forecasts

Reasons to buy

- What was the size of the Japan biotechnology market by value in 2018?
- What will be the size of the Japan biotechnology market in 2023?
- What factors are affecting the strength of competition in the Japan biotechnology market?
- How has the market performed over the last five years?
- What are the main segments that make up Japan's biotechnology market?

Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Category segmentation
1.4. Geography segmentation
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Category segmentation
4.2. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players in the market?
7.2. What strategies do leading players follow?
7.3. Have there been any new product launches in recent years?
7.4. What has been the rationale behind recent M&A activity?
7.5. Are there any threats to leading players?
8 Company Profiles
8.1. Bunge Limited
8.2. Mitsubishi Tanabe Pharma Corporation
8.3. Daiichi Sankyo Co Ltd
8.4. Takeda Pharmaceutical Company Limited
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine